Standout Papers

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients w... 2008 2026 2014 2020 1.0k
  1. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) (2008)
    Kim Papp, Richard G. Langley et al. The Lancet

Immediate Impact

1 by Nobel laureates 20 from Science/Nature 101 standout
Sub-graph 1 of 17

Citing Papers

Active biointegrated living electronics for managing inflammation
2024 StandoutScience
Dictionary of immune responses to cytokines at single-cell resolution
2023 StandoutNature
3 intermediate papers

Works of Ming-Chun Hsu being referenced

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
2008 Standout

Author Peers

Author Last Decade Papers Cites
Ming-Chun Hsu 1484 122 274 797 310 14 1.7k
Norman Wasel 1576 85 318 918 378 20 1.9k
Enrique Rivas 1317 74 242 733 328 12 1.7k
Mary Flack 1277 89 191 763 189 22 1.4k
Silvia Helou 1261 49 238 702 323 16 1.7k
Isabelle Hampele 1298 54 253 722 335 8 1.5k
Marianne Notter 1257 50 243 706 333 9 1.6k
Thomas Salko 1258 50 237 695 324 5 1.5k
Darryl Toth 1161 79 272 918 312 33 1.7k
Emily Edson‐Heredia 1314 66 224 958 343 38 1.8k
Gregory Kricorian 1345 66 195 701 375 22 1.6k

All Works

Loading papers...

Rankless by CCL
2026